Mitoglitazone

DB11721InvestigationalSmall molecule

Mitoglitazone has been used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.

Chemical structure of Mitoglitazone
Formula / weight
C19H18N2O4S · 370.422 g/mol (avg)
Also known as
MSDC-0160

Resolves to

Compound
UNII29I7RP18RGCAS146062-49-9ChEMBLCHEMBL146624ChEBI94409PubChem10429242
Structure
InChIKeyIRNJSRAGRIZIHD-UHFFFAOYSA-NSMILESCCC1=CN=C(C=C1)C(=O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1
Targets
P06213INSR

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Mitoglitazone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In